34 The TGF-beta2 antisense ollgonucleotide ap 12009 as a therapeutic agent in recurrent high-grade glloma: safety and efficacy results of phase I/II clinical trials

✍ Scribed by P. Hau; U. Bogdahn; J. Schlaier; M. Mehdorn; G. Wurm; J. Pichier; M. Kunst; M. Goldbrunner; K.H. Schlingensiepen; G. Stauder

• Book ID: 118620210
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 169 KB
• Volume: 1
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(03)90068-1